BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Iktos

Iktos logo

Founded
2017
Geography
France based
Funding
$2.023 M

Iktos is a French start-up company which develops a truly innovative and disruptive artificial intelligence technology for ligand-based de novo drug design, focusing on MPO (multi parametric optimization).

Our innovative algorithm is based on state of the art deep learning models, called generative models, and enables to design new, druggable and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance.

Technologies

AI Companies (Drug Discovery)  

R&D Platform

Iktos has invented and is developing a a technology based on DL for ligand-based de novo drug design, focusing on multi parametric optimization (MPO).


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet